CGTX
CGTX
NASDAQ · Pharmaceuticals

Cognition Therapeutics Inc

$1.04
-0.02 (-1.89%)
As of Sep 20, 10:47 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,876.9% upside
Low Target $22.83
Average Target $30.96
High Target $36.58
Current Price $1.04
Current
$1.04
Target
$30.96
$22.83 $30.96 avg $36.58
Scenario Analysis
Bear Case
$22.83
2,095.2%
Low target
Base Case
$30.96
+2,876.9%
Avg target
Bull Case
$36.58
+3,417.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$2.05
-49.3% from high
52-Week Low
$0.55
+89.1% from low
Target vs 52W High
$30.96
+1,410.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%